Patent intelligence · US
US 9737520
Aclidinium for use in improving the quality of sleep in respiratory patients
Aclidinium for use in improving the quality of sleep in respiratory patients
Patent details — US 9737520
- Jurisdiction
- US
- Status
- granted
- Grant date
- Aug 22, 2017
- Expiration
- Aug 17, 2037
- Applicant
- Almirall, S.A.
- Claims
- 15
- CPC classes
- A61K, A61K31/439, A61K45/06, A61K9/0073
Quick answer
US 9737520 (Aclidinium for use in improving the quality of sleep in respiratory patients) is held by Almirall, S.A.. Status: granted. Granted Aug 22, 2017. Expires Aug 17, 2037 (11 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Almirall, S.A.
- Grant date
- Expiration
- Claims
- 15
- CPC classes
- A61K, A61K31/439, A61K45/06, A61K9/0073, A61K9/0075, A61P
More from Almirall, S.A.
Related pharmaceutical patents in our USPTO index.
-
US 12421228
Naphthyridine derivatives as PRC2 inhibitors
granted -
US 12421253
Tetrahydropyridopyrimidine pan-KRas inhibitors
granted -
US 12414911
Topical compositions and methods of use
granted -
US 12412764
Substrate-accommodating container
granted -
US 12398154
Azaquinazoline pan-KRas inhibitors
granted -
US 12383503
Adagrasib solid pharmaceutical compositions
granted -
US 12377101
Combination therapies
granted -
US 12371435
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
granted
Frequently asked questions
What is US patent 9737520?
US 9737520 (Aclidinium for use in improving the quality of sleep in respiratory patients) is held by Almirall, S.A.. Status: granted. Granted Aug 22, 2017. Expires Aug 17, 2037 (11 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 9737520?
Almirall, S.A. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 308 pharmaceutical patents for this assignee.
When does US 9737520 expire?
Our index shows an expiration date of Aug 17, 2037 (11 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.